Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $80.84 -1.41%
EPS Growth %: +4.8%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +4.8%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of $0.22, $0.10 better than the analyst estimate of $0.12. Revenue for the quarter came in at $264.03 million versus the consensus estimate of $227.61 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
- Active options: MSFT PLTR META GOOGL SOFI MSTR IREN AMC IBM SMCI HOOD AMD
- Tenable Holdings, Inc. (TENB) call put ratio 80 calls to 1 put with a focus on 200 contracts of July 32 calls as share price up 5.6%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
